India may get a Covid-19 vaccine as early as March since several manufacturers are working on it, according to Dr Suresh Jadhav, executive director of Serum Institute of India. The institute is working with Oxford University and AstraZeneca to develop a Covid-19 vaccine in India.
Dr Jadhav said that provided regulators approve the vaccine candidates, India is moving fast towards having a vaccine for Covid-19. He said two manufacturers are already in phase-III trial and one in phase-II trial and more are joining, all indicating positive developments in the global race for a vaccine.
The spread of the novel coronavirus in India has quickened in the last few days with new cases of Covid-19 and deaths reported every day. The pandemic has expanded its footprint in the country and has affected over 74 lakh people since the first positive case was confirmed on January 30 in Kerala. India's Covid-19 death toll stands at 1,12,910.